BioMed Realty Trust (NYSE:BMR) will be releasing its Q214 earnings data on Tuesday, August 5th. Analysts expect BioMed Realty Trust to post earnings of $0.36 per share and revenue of $160.80 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
BioMed Realty Trust (NYSE:BMR) opened at 21.44 on Monday. BioMed Realty Trust has a 1-year low of $17.90 and a 1-year high of $22.47. The stock’s 50-day moving average is $21.88 and its 200-day moving average is $20.83. The company has a market cap of $4.093 billion and a P/E ratio of 87.40.
BMR has been the subject of a number of recent research reports. Analysts at Jefferies Group raised their price target on shares of BioMed Realty Trust from $23.00 to $25.00 in a research note on Tuesday, July 22nd. On a related note, analysts at MLV & Co
initiated coverage on shares of BioMed Realty Trust in a research note on Friday, June 27th. They set a “hold” rating and a $23.00 price target on the stock. Finally, analysts at Robert W. Baird raised their price target on shares of BioMed Realty Trust from $22.00 to $23.00 in a research note on Tuesday, May 13th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. BioMed Realty Trust has a consensus rating of “Buy” and an average price target of $23.14.
BioMed Realty Trust, Inc operates as a real estate investment trust (NYSE:BMR), and the general partner of BioMed Realty, L.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.